{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T20:50:10Z","timestamp":1789678210092,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejmech.2019.06.046","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T11:14:44Z","timestamp":1560942884000},"page":"166-181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"special_numbering":"C","title":["A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV"],"prefix":"10.1016","volume":"179","author":[{"given":"Liang-Liang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narsaiah","family":"Battini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rammohan R. Yadav","family":"Bheemanaboina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Fawad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Ping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Peng","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Xin","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2259-7704","authenticated-orcid":false,"given":"Shao-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3233-5465","authenticated-orcid":false,"given":"Cheng-He","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.06.046_bib1a","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ejmech.2018.08.061","article-title":"Quinolone derivatives and their activities against methicillin-resistant Staphylococcus aureus (MRSA)","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib1b","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature13147","article-title":"Unexpected link between an antibiotic, pannexin channels and apoptosis","volume":"507","author":"Poon","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.06.046_bib2a","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nsmb.1604","article-title":"Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases","volume":"16","author":"Laponogov","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2019.06.046_bib2b","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2174\/1389450033346920","article-title":"Fluoroquinolones: structure and target sites","volume":"4","author":"Higgins","year":"2003","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.ejmech.2019.06.046_bib2c","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1002\/anie.201209979","article-title":"Combating multidrug-resistant bacteria: current strategies for the discovery of novel antibacterials","volume":"52","author":"O'Connell","year":"2013","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.06.046_bib2d","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/nature09197","article-title":"Type IIA topoisomerase inhibition by a new class of antibacterial agents","volume":"466","author":"Bax","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.06.046_bib2e","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1021\/jm501881c","article-title":"Origins of the quinolone class of antibacterials: an expanded \u201cdiscovery story\u201d","volume":"58","author":"Bisacchi","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib3","doi-asserted-by":"crossref","first-page":"32281","DOI":"10.1038\/srep32281","article-title":"Plasmid-mediated quinolone resistance determinants in quinolone-resistant Escherichia coli isolated from patients with bacteremia in a university hospital in Taiwan, 2001\u20132015","volume":"6","author":"Kao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2019.06.046_bib4a","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejmech.2017.09.050","article-title":"4-Quinolone hybrids and their antibacterial activities","volume":"141","author":"Hu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib4b","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejmech.2017.11.082","article-title":"4-Quinolone derivatives and their activities against Gram positive pathogens","volume":"143","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib5a","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejmech.2018.08.095","article-title":"Recent developments of quinolone-based derivatives and their activities against Escherichia coli","volume":"157","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib5b","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejmech.2018.10.035","article-title":"Quinoline and quinolone dimers and their biological activities: an overview","volume":"161","author":"Chu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib6a","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1021\/cr030101q","article-title":"Bacterial topoisomerase inhibitors: quinolone and pyridone antibacterial agents","volume":"105","author":"Mitscher","year":"2005","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.06.046_bib6b","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nature13147","article-title":"Unexpected link between an antibiotic, pannexin channels and apoptosis","volume":"507","author":"Poon","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2019.06.046_bib7","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.4155\/fmc-2017-0108","article-title":"Antimicrobial 2-aminothiazolyl quinolones: what is their potential in the clinic?","volume":"9","author":"Gao","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib8a","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1021\/jm000153x","article-title":"Synthesis, antibacterial, and cytotoxic evaluation of certain 7-substituted norfloxacin derivatives","volume":"43","author":"Fang","year":"2000","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib8b","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1016\/j.bmcl.2015.06.041","article-title":"Design and biological evaluation of novel quinolone-based metronidazole derivatives as potent Cu2+ mediated DNA-targeting antibacterial agents","volume":"25","author":"Zhang","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib8c","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejmech.2016.01.052","article-title":"Discovery of membrane active benzimidazole quinolones-based topoisomerase inhibitors as potential DNA-binding antimicrobial agents","volume":"111","author":"Zhang","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib9a","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/med.21290","article-title":"Comprehensive review in current developments of imidazole-based medicinal chemistry","volume":"34","author":"Zhang","year":"2014","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2019.06.046_bib9b","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/092986712803414213","article-title":"Recent researches in triazole compounds as medicinal drugs","volume":"19","author":"Zhou","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib9c","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1360\/N032018-00098","article-title":"Researches and applications of nitroimidazole heterocycles in medicinal chemistry","volume":"49","author":"Li","year":"2019","journal-title":"Sci. Sin. Chim."},{"key":"10.1016\/j.ejmech.2019.06.046_bib10a","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2174\/15680266113139990125","article-title":"Recent developments in azole compounds as antibacterial and antifungal agents","volume":"13","author":"Peng","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib10b","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.2174\/1381612811319210013","article-title":"Current developments of coumarin compounds in medicinal chemistry","volume":"19","author":"Peng","year":"2013","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.ejmech.2019.06.046_bib11a","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/cmdc.201700739","article-title":"Discovery of benzimidazole-quinolone hybrids as new cleaving agents toward drug-resistant Pseudomonas aeruginosa DNA","volume":"13","author":"Wang","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.06.046_bib11b","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/cbdd.12532","article-title":"Design, synthesis, and antimicrobial evaluation of novel quinolone imidazoles and interactions with MRSA DNA","volume":"86","author":"Zhang","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2019.06.046_bib11c","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejmech.2014.08.063","article-title":"Novel hybrids of metronidazole and quinolones: synthesis, bioactive evaluation, cytotoxicity, preliminary antimicrobial mechanism and effect of metal ions on their transportation by human serum albumin","volume":"86","author":"Cui","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib12a","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1021\/jm500462x","article-title":"Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099)","volume":"57","author":"Basarab","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib12b","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1021\/acsmedchemlett.7b00452","article-title":"Novel naphthalimide aminothiazoles as potential multitargeting antimicrobial agents","volume":"8","author":"Chen","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib13a","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1021\/bi101167x","article-title":"Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in neisseria gonorrhoeae: role of epistatic mutations","volume":"49","author":"Tomberg","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2019.06.046_bib13b","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1021\/acs.oprd.7b00143","article-title":"Patent review of manufacturing routes to fifth-generation cephalosporin drugs. part 2, ceftaroline fosamil and ceftobiprole medocaril","volume":"21","author":"Hughes","year":"2017","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejmech.2019.06.046_bib13c","doi-asserted-by":"crossref","first-page":"4504","DOI":"10.1016\/j.bmcl.2016.07.068","article-title":"Synthesis and bioactivities of novel pyrazole oxime derivatives containing a 1,2,3-thiadiazole moiety","volume":"26","author":"Dai","year":"2016","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.06.046_bib14a","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejmech.2011.10.048","article-title":"Synthesis and antibacterial activity of naphthyridone derivatives containing mono\/difluoro-methyloxime pyrrolidine scaffolds","volume":"47","author":"Lv","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib14b","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.ejmech.2014.09.029","article-title":"Synthesis, antimycobacterial and antibacterial evaluation of l-[(1R, 2S)-2-fluorocyclopropyl]fluoroquinolone derivatives containing an oxime functional moiety","volume":"86","author":"Liu","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib15a","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1128\/AAC.01407-05","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activities of DW-224a, a new fluoronaphthyridone","volume":"50","author":"Park","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.06.046_bib15b","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1128\/AAC.46.9.3071-3074.2002","article-title":"In\u00a0vitro and in\u00a0vivo antibacterial activities of DW286, a new fluoronaphthyridone antibiotic","volume":"46","author":"Yun","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.06.046_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejmech.2015.07.026","article-title":"Piperazine scaffold: a remarkable tool in generation of diverse pharmacological agents","volume":"102","author":"Shaquiquzzaman","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib17a","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1021\/acs.jmedchem.7b00738","article-title":"Design and synthesis of orally bioavailable piperazine substituted 4(1H)-quinolones with potent antimalarial activity: structure-activity and structure-property relationship studies","volume":"61","author":"Neelarapu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib17b","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ejmech.2019.01.072","article-title":"Design and synthesis of aminothiazolyl norfloxacin analogues as potential antimicrobial agents and their biological evaluation","volume":"167","author":"Wang","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib18a","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1021\/acs.jmedchem.5b01678","article-title":"Novel 3-aminothiazolquinolones: design, synthesis, bioactive evaluation, SARs, and preliminary antibacterial mechanism","volume":"59","author":"Cui","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib18b","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ejmech.2016.10.011","article-title":"Multi-targeting exploration of new 2-aminothiazolyl quinolones: synthesis, antimicrobial evaluation, interaction with DNA, combination with topoisomerase IV and penetrability into cells","volume":"124","author":"Cheng","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib19","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically","year":"2006"},{"key":"10.1016\/j.ejmech.2019.06.046_bib20a","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ejmech.2016.06.031","article-title":"Design, synthesis and biological evaluation of berberine-benzimidazole hybrids as new type of potentially DNA-targeting antimicrobial agents","volume":"122","author":"Jeyakkumar","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib20b","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bmcl.2013.11.013","article-title":"1,2,3-Triazole-derived naphthalimides as a novel type of potential antimicrobial agents: synthesis, antimicrobial activity, interaction with calf thymus DNA and human serum albumin","volume":"24","author":"Lv","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib21a","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11426-016-9009-6","article-title":"Design, synthesis and biological evaluation of amino organophosphorus imidazoles as a new type of potential antimicrobial agents","volume":"60","author":"Gao","year":"2017","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib21b","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejmech.2018.01.038","article-title":"Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumanii","volume":"146","author":"Gao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ejmech.2018.06.022","article-title":"Novel carbazole-triazole conjugates as DNA-targeting membrane active potentiators against clinical isolated fungi","volume":"155","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib23a","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1021\/jm5013566","article-title":"Membrane-active phenylalanine-conjugated lipophilic norspermidine derivatives with selective antibacterial activity","volume":"57","author":"Konai","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib23b","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1021\/acs.molpharmaceut.8b01021","article-title":"Sulfonamide-derived four-component molecular hybrids as novel DNA-targeting membrane active potentiators against clinical Escherichia coli","volume":"16","author":"Hu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejmech.2019.06.046_bib24","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2174\/1389201017666160808160513","article-title":"Cell proliferation and cytotoxicity assays","volume":"17","author":"Adan","year":"2016","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.06.046_bib25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1021\/acsmedchemlett.7b00514","article-title":"Potential antimicrobial isopropanol-conjugated carbazole azoles as dual targeting inhibitors of Enterococcus faecalis","volume":"9","author":"Zhang","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11426-017-9169-4","article-title":"Discovery of natural berberine-derived nitroimidazoles as potentially multi-targeting agents against drug-resistant Escherichia coli","volume":"61","author":"Zhang","year":"2018","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib27a","doi-asserted-by":"crossref","first-page":"8941","DOI":"10.1021\/acs.jmedchem.6b00864","article-title":"Discovery of benzothiazole scaffold-based DNA gyrase B inhibitors","volume":"59","author":"Gjorgjieva","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib27b","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.1021\/acs.jmedchem.7b01202","article-title":"Discovery of novel topoisomerase II inhibitors by medicinal chemistry approaches","volume":"61","author":"Hu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib28a","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.bmcl.2018.03.046","article-title":"Novel purine benzimidazoles as antimicrobial agents by regulating ROS generation and targeting clinically resistant Staphylococcus aureus DNA groove","volume":"28","author":"Wang","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib28b","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.4155\/fmc-2016-0002","article-title":"Quinazolinone azolyl ethanols: potential lead antimicrobial agents with dual action modes targeting MRSA DNA","volume":"8","author":"Peng","year":"2016","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib29a","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1021\/jacs.6b02699","article-title":"Silver-lactoferrin nanocomplexes as a potent antimicrobial agent","volume":"138","author":"Pomastowski","year":"2016","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2019.06.046_bib29b","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1016\/j.bmcl.2013.04.039","article-title":"Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A\/B kinase inhibitors","volume":"23","author":"Zheng","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib30a","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1021\/acs.analchem.7b01343","article-title":"Parallel evaluation of melting temperatures of DNAs in the arrayed droplets through the fluorescence from DNA intercalators","volume":"89","author":"Shimazaki","year":"2017","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib30b","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1039\/C6MD00357E","article-title":"Design, synthesis, and biological evaluation of novel carbazole aminothiazoles as potential DNA targeting antimicrobial agents","volume":"7","author":"Addla","year":"2016","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.06.046_bib31a","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ejmech.2016.02.059","article-title":"Synthesis and biological evaluation of pyrrolo[2,3-b]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA","volume":"114","author":"Narva","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib31b","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejmech.2013.11.003","article-title":"Synthesis and biological evaluation of a-triazolyl chalcones as a new type of potential antimicrobial agents and their interaction with calf thymus DNA and human serum albumin","volume":"71","author":"Yin","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib31c","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1007\/s11426-014-5087-x","article-title":"Design, synthesis, and biological evaluation of novel benzimidazole derivatives and their interaction with calf thymus DNA and synergistic effects with clinical drugs","volume":"57","author":"Zhang","year":"2014","journal-title":"Sci. China Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib32a","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.bmcl.2016.04.036","article-title":"Design, synthesis and biological evaluation of 5-fluorouracil-derived benzimidazoles as novel type of potential antimicrobial agents","volume":"26","author":"Fang","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib32b","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1039\/C4MD00266K","article-title":"Synthesis of tetrazole compounds as a novel type of potential antimicrobial agents and their synergistic effects with clinical drugs and interactions with calf thymus DNA","volume":"6","author":"Dai","year":"2015","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.06.046_bib33a","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1039\/C8MD00301G","article-title":"Novel organophosphorus aminopyrimidines as unique structural DNA-targeting membrane active inhibitors towards drug-resistant methicillin-resistant Staphylococcus aureus","volume":"9","author":"Li","year":"2018","journal-title":"Med. Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.06.046_bib33b","doi-asserted-by":"crossref","first-page":"711","DOI":"10.4155\/fmc-2017-0160","article-title":"Novel naphthalimide nitroimidazoles as multitargeting antibacterial agents against resistant Acinetobacter baumannii","volume":"10","author":"Kang","year":"2018","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib34","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1016\/j.bmcl.2017.10.020","article-title":"Novel potentially antifungal hybrids of 5-flucytosine and fluconazole: design, synthesis and bioactive evaluation","volume":"27","author":"Fang","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib35a","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.1021\/jf2019006","article-title":"Molecular spectroscopic studies of farrerol interaction with calf thymus DNA","volume":"59","author":"Zhang","year":"2011","journal-title":"J.\u00a0Agric. Food Chem."},{"key":"10.1016\/j.ejmech.2019.06.046_bib35b","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1016\/j.bmcl.2018.06.016","article-title":"Azoalkyl ether imidazo[2,1-b]benzothiazoles as potentially antimicrobial agents with novel structural skeleton","volume":"28","author":"Maddili","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.06.046_bib36a","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1021\/bm100814n","article-title":"Interactions between antimalarial indolone-N-oxide derivatives and human serum albumin","volume":"11","author":"Ibrahim","year":"2010","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejmech.2019.06.046_bib36b","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1039\/C8QO01180J","article-title":"Novel potential artificial MRSA DNA intercalators: synthesis and biological evaluation of berberine derived thiazolidinediones","volume":"6","author":"Sun","year":"2019","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.ejmech.2019.06.046_bib37a","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1002\/adsc.201400442","article-title":"Palladium-catalyzed suzuki carbonylative reaction of \u03b1-halomethyl oxime ethers: a regioselective route to unsymmetrical 1,3-oxyiminoketones","volume":"356","author":"Noverges","year":"2014","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2019.06.046_bib37b","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1016\/j.bmcl.2012.07.064","article-title":"Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents","volume":"22","author":"Wang","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419305732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419305732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:57:33Z","timestamp":1759327053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419305732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":73,"alternative-id":["S0223523419305732"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.046","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A new exploration towards aminothiazolquinolone oximes as potentially multi-targeting antibacterial agents: Design, synthesis and evaluation acting on microbes, DNA, HSA and topoisomerase IV","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}